What ' s known on the subject? and What does the study add? The European Medicines Evaluation Agency recognised that the principal advantage of degarelix is the avoidance of the transient rise in testosterone. This paper compares the cost-effectiveness of degarelix with the most common treatment in the UK (LHRHa plus short-term anti-androgen) for the management of prostate cancer, focusing on the costs and clinical consequences that might be associated by the avoidance of the transient rise in testosterone. Our analysis suggests that, at the current UK list price, degarelix would not represent good value for money for the NHS.
Using a willingness-to-pay threshold of £30 000 per QALY, Sativex® appears unlikely to be considered cost effective by UK funders of healthcare for spasticity in MS. This is unfortunate, since it appears that Sativex® use is likely to benefit some patients in the management of this common consequence of MS.
Alemtuzumab appears more likely to be cost-effective if used earlier in the course of T-PLL and where it replaces the use of multiple alternative therapies. However, cost-effectiveness is highly uncertain and future research is clearly justified. Nevertheless, our analysis demonstrates the feasibility of considering the cost-effectiveness of an agent despite the presence of significant uncertainty to provide appropriate assessment information to policy makers.
allowed to move around the device within 10 cm. radius. After 28 days, mRNA from the brain of control, sham and GSM-900 MHz exposed rats were isolated and subjected to quantitative Real Time Polymerase Chain Reaction (qRT-PCR) array analysis. Gene expression was measured and expressed in fold change as described by Bandhyopadhay et.al. (2007). The qRT-PCR was performed by using sybr green chemistry on ABI 7900HT platform. The real time quantification of amplification was done by measuring change in fluorescence by SDS2.3 software and further analyze by RQ manager. RESULTS: Thus the results obtained from this study have shown that there is no significant change in expressions of genes involved in DNA damage and repair pathways such as chromatin assembly (CHAF1A), DNA damage checkpoints (Chk1), DNA synthesis (POLD1), posttranscriptional processes (RBM4), translation synthesis (POLI) and stress signaling (Hsp90) as compared with controls. CONCLUSIONS: Mobile phone's acute exposure (GSM900MHz) does not support for genes expression involved in DNA damage and repair pathways.
We evaluate the Arrows Classification Method (ACM) for grouping objects based on the similarity of their data. This is a new method, which aims to achieve a balance between the conflicting objectives of maximizing internal cohesion and external isolation in the output groups. The method is widely applicable, especially in simulation input and output modelling, and has previously been used for grouping machines on an assembly line, based on data on time-to-repair; and hospital procedures, based on length-of-stay data. The similarity of the data from a pair of objects is measured using the two-sample Cramér-von-Mises goodness of fit statistic, with bootstrapping employed to find the significance or p-value of the calculated statistic. The p-values coming from the paired comparisons serve as inputs to the ACM, and allow the objects to be classified such that no pair of objects that are grouped together have significantly different data. In this article, we give the technical details of the method and evaluate its use through testing with specially generated samples. We will also demonstrate its practical application with two real examples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.